FdaApplication
ANDA 202894
Identifiers
- fda_app_no: ANDA202894
Properties
| Property | Value |
|---|---|
| applicant_name | GLENMARK SPECIALTY SA |
| application_type | ANDA |
| approval_date | 2015-10-30 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE | EQ 0.05% BASE;1% | CREAM;TOPICAL |
1 product